Based on our false positive findings and the available literature, PSMA-avid differential diagnosis, such as vascular disorders (hemangiomas, perfusional defects) and hepatic diseases (hepatitis, hepatocarcinoma), should be considered when assessing the liver parenchyma with PSMA-PET [29,30,31,32]. The gene discussed is FOLH1; the disease is hemangioma.